SCHEMBL20415293

SCHEMBL20415293

C#CCCCCNC(=O)O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.50
CYP2D6 P10635 2/20 0.50
MAPT P10636 1/20 0.50
CYP2C9 P11712 1/20 0.50
CYP2C19 P33261 1/20 0.50
HSD17B10 Q99714 1/20 0.50
ALDH1A1 P00352 3/20 0.39
KDM4E B2RXH2 2/20 0.39
HPGD P15428 1/20 0.39
CYP3A4 P08684 1/20 0.38
EPHX2 P34913 3/20 0.37
MAPK1 P28482 1/20 0.36
HIF1A Q16665 1/20 0.36
PRMT1 Q99873 1/20 0.35
SMN1; SMN2 Q16637 2/20 0.34
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
POLB P06746 1/20 0.33
ADRA1A P35348 1/20 0.33
CA12 O43570 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL537445 0.98 CYP1A2 (0.54) CYP1A2CYP2D6MAPTCYP2C9CYP2C19
SCHEMBL28312759 0.98 CYP1A2 (0.54) CYP1A2CYP2D6MAPTCYP2C9CYP2C19
SCHEMBL16499782 0.93
SCHEMBL476298 0.83
SCHEMBL22609473 0.81 TSHR (0.38) CYP1A2CYP2D6MAPTCYP2C9CYP2C19
SCHEMBL23131068 0.80 CYP1A2 (0.43) CYP1A2CYP2D6MAPTCYP2C9CYP2C19
SCHEMBL21887121 0.80 KDM4E (0.62) CYP1A2CYP2D6MAPTCYP2C9CYP2C19
SCHEMBL18072519 0.80 CYP1A2 (0.43) CYP1A2CYP2D6MAPTCYP2C9CYP2C19
SCHEMBL3174690 0.80 KDM4E (0.50) CYP2D6MAPTCYP2C19ALDH1A1KDM4E
SCHEMBL20574016 0.79 CYP1A2 (0.40) CYP1A2CYP2D6MAPTCYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4334307-A1 CDK2 DEGRADERS AND USES THEREOF Kymera Therapeutics, Inc. (US) 2024-03-13 EP disclosed
WO-2023110970-A1 MACROCYCLIC BTK INHIBITORS NETHERLANDS TRANSLATIONAL RESEARCH CENTER HOLDING B.V (NL) 2023-06-22 WO disclosed
WO-2023110936-A1 REVERSIBLE MACROCYCLIC KINASE INHIBITORS NETHERLANDS TRANSLATIONAL RESEARCH CENTER HOLDING B.V (NL) 2023-06-22 WO disclosed
WO-2022236058-A1 CDK2 DEGRADERS AND USES THEREOF KYMERA THERAPEUTICS, INC. (US) 2022-11-10 WO disclosed
CN-115315263-A Cell surface receptor binding compounds and conjugates 利西亚治疗公司 2022-11-08 CN disclosed
CN-112673015-A CXCR 4-targeted diagnostic and therapeutic agents with reduced species selectivity 慕尼黑工业大学 2021-04-16 CN disclosed
US-20180209953-A1 TRANSLOCATION OF A POLYMER THROUGH A NANOPORE ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNVERSITY 2018-07-26 US disclosed